Collectively, these data indicated that MALAT1 may act as an endogenous ‘ceRNA’ through binding to miR-183, thus eliminating the miR183-mediated inhibitory effects on the ITGB1 expression and its downstream signalling events in melanoma (Figure 7). The gene discussed is ITGB1; the disease is melanoma.